AIP Quote, Financials, Valuation and Earnings

Advanced Micro Devices has a net margin of -52.97% compared to Arteris's net margin of 6.29%. Arteris's return on equity of -543.51% beat Advanced Micro Devices's return on equity of 2.9%.

Arteris has a consensus price target of $12.50, signalling upside risk potential of 107.99%. On the other hand Advanced Micro Devices has an analysts' consensus of $144.34 which suggests that it could grow by 51.47%. Given that Arteris has higher upside potential than Advanced Micro Devices, analysts believe Arteris is more attractive than Advanced Micro Devices.

Arteris has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Advanced Micro Devices has a beta of 1.887, suggesting its more volatile than the S&P 500 by 88.664%.

Arteris has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Advanced Micro Devices offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arteris pays -- of its earnings as a dividend. Advanced Micro Devices pays out -- of its earnings as a dividend.

Arteris quarterly revenues are $15.5M, which are smaller than Advanced Micro Devices quarterly revenues of $7.7B. Arteris's net income of -$8.2M is lower than Advanced Micro Devices's net income of $482M. Notably, Arteris's price-to-earnings ratio is -- while Advanced Micro Devices's PE ratio is 96.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arteris is 4.05x versus 6.05x for Advanced Micro Devices. Usually stocks with elevated PS ratios are considered overvalued.

Amkor Technology has a net margin of -52.97% compared to Arteris's net margin of 6.49%. Arteris's return on equity of -543.51% beat Amkor Technology's return on equity of 8.64%.

Arteris has a consensus price target of $12.50, signalling upside risk potential of 107.99%. On the other hand Amkor Technology has an analysts' consensus of $29.05 which suggests that it could grow by 70.07%. Given that Arteris has higher upside potential than Amkor Technology, analysts believe Arteris is more attractive than Amkor Technology.

Arteris has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amkor Technology has a beta of 1.883, suggesting its more volatile than the S&P 500 by 88.321%.

Arteris has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amkor Technology offers a yield of 1.89% to investors and pays a quarterly dividend of $0.08 per share. Arteris pays -- of its earnings as a dividend. Amkor Technology pays out 50.45% of its earnings as a dividend. Amkor Technology's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arteris quarterly revenues are $15.5M, which are smaller than Amkor Technology quarterly revenues of $1.6B. Arteris's net income of -$8.2M is lower than Amkor Technology's net income of $105.6M. Notably, Arteris's price-to-earnings ratio is -- while Amkor Technology's PE ratio is 11.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arteris is 4.05x versus 0.67x for Amkor Technology. Usually stocks with elevated PS ratios are considered overvalued.

Ascent Solar Technologies has a net margin of -52.97% compared to Arteris's net margin of -19776.22%. Arteris's return on equity of -543.51% beat Ascent Solar Technologies's return on equity of -12974.47%.

Arteris has a consensus price target of $12.50, signalling upside risk potential of 107.99%. On the other hand Ascent Solar Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Arteris has higher upside potential than Ascent Solar Technologies, analysts believe Arteris is more attractive than Ascent Solar Technologies.

Arteris has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ascent Solar Technologies has a beta of 2.293, suggesting its more volatile than the S&P 500 by 129.254%.

Arteris has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ascent Solar Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arteris pays -- of its earnings as a dividend. Ascent Solar Technologies pays out -- of its earnings as a dividend.

Arteris quarterly revenues are $15.5M, which are larger than Ascent Solar Technologies quarterly revenues of $8.6K. Arteris's net income of -$8.2M is lower than Ascent Solar Technologies's net income of -$1.7M. Notably, Arteris's price-to-earnings ratio is -- while Ascent Solar Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arteris is 4.05x versus 26.15x for Ascent Solar Technologies. Usually stocks with elevated PS ratios are considered overvalued.

inTest has a net margin of -52.97% compared to Arteris's net margin of 4.11%. Arteris's return on equity of -543.51% beat inTest's return on equity of 2.92%.

Arteris has a consensus price target of $12.50, signalling upside risk potential of 107.99%. On the other hand inTest has an analysts' consensus of $12.67 which suggests that it could grow by 109.02%. Given that inTest has higher upside potential than Arteris, analysts believe inTest is more attractive than Arteris.

Arteris has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison inTest has a beta of 1.700, suggesting its more volatile than the S&P 500 by 70.048%.

Arteris has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. inTest offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arteris pays -- of its earnings as a dividend. inTest pays out -- of its earnings as a dividend.

Arteris quarterly revenues are $15.5M, which are smaller than inTest quarterly revenues of $36.6M. Arteris's net income of -$8.2M is lower than inTest's net income of $1.5M. Notably, Arteris's price-to-earnings ratio is -- while inTest's PE ratio is 26.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arteris is 4.05x versus 0.57x for inTest. Usually stocks with elevated PS ratios are considered overvalued.